Roche Babesia test receives FDA approval

Roche announced Friday that it has received approval from the U.S. Food and Drug Administration (FDA) for the cobas Babesia test for use on the cobas 6800/8800 Systems for individual blood donation testing. This is Roche's first commercially available whole blood test to screen donations and follows May 2019 FDA-updated industry guidance recommending screening and ["]

The post Roche Babesia test receives FDA approval appeared first on Outbreak News Today.